BRAF and melanoma: The BRAF alteration pattern was similar to the TCGA cohort—the frequency of BRAF mutations in desert group was nearly two-fold lower than in the inflamed and excluded groups, where half or more patients had tumors with altered BRAF. However, the differences among real-world melanoma cohort subtypes did not reach the statistical significance level (p = 0.067).